The evolving landscape of glaucoma treatment involves advancements in interventional glaucoma therapy, which leverages various treatment modalities early in the disease course to enhance intraocular pressure (IOP) control and improve long-term outcomes. The paradigm shift emphasizes comprehensive IOP control through treatments such as selective laser trabeculoplasty (SLT), minimally invasive glaucoma surgeries (MIGS), and procedural pharmaceuticals, and aims to target multiple mechanisms, including trabecular and uveoscleral outflow, aqueous suppression, and episcleral venous pressure. Researchers noted that this approach represents the best chance to prevent glaucoma progression over time. 

Source: Ophthalmology and Therapy